Bortezomib (VELCADE), Cladribine and Rituximab (VCR) in Mantle Cell Lymphoma (PSHCI 10-011)

NCT01439750 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Mantle Cell Lymphoma

Interventions

DRUG: Rituximab
DRUG: bortezomib
DRUG: Cladribine

Sponsor

Milton S. Hershey Medical Center